Skip to main content

Month: September 2021

Mercer International Inc. to Present at Upcoming TD Securities 2021 Virtual Paper & Forest Products Conference

NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) — Mercer International Inc. (Nasdaq: MERC) today announced that David M. Gandossi, President and CEO, will be presenting at the following upcoming conference: TD Securities Virtual Paper & Forest Products ConferenceWednesday, September 29th, 2021Presentation at 10:00 AM EDT A copy of the presentation will be posted in the “Investors – News releases & Presentations” section on the Company’s web site (https://mercerint.com/investors/news-releases-presentations/) on the morning of the event. A webcast of the presentation will be shared a few days ahead of the conference in the “Investors – Events & Calendar” section on the Company’s web site (https://mercerint.com/investors/events-calendar/) and a recording of the session will be available for playback for ninety...

Continue reading

Beyond Air® Provides Global Regulatory Update for LungFit® PH

FDA inspection of facilities is ongoing; US commercial launch remains on track for 4Q CY2021, pending FDA approval Stage 1 Assessment Audit in the CE Mark process is complete; expect to receive CE Mark in 1H CY2022 GARDEN CITY, N.Y., Sept. 21, 2021 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO (gNO) for the treatment of solid tumors, today provided an update on the global regulatory approval process for the LungFit® PH system.Beyond Air has successfully completed the Stage 1 Assessment Audit of its quality system conducted by the Notified Body for the LungFit® PH system, a necessary...

Continue reading

Ecolab Schedules Webcast and Conference Call on October 26

ST. PAUL, Minn., Sept. 21, 2021 (GLOBE NEWSWIRE) — Ecolab will host a live webcast of its third quarter earnings conference call to discuss 2021 third quarter results. A news release containing third quarter results is expected to be issued before market open on Oct. 26, 2021. Details for the public webcast are as follows:TIME:   1:00 p.m. Eastern TimeDATE:   Tuesday, Oct. 26, 2021DURATION:   One hourLOCATION:   www.ecolab.com/investor ARCHIVE:   A replay of the webcast and supplemental data will be available on Ecolab’s website.     About EcolabA trusted partner at nearly three million customer locations, Ecolab (ECL) is the global leader in water, hygiene and infection prevention solutions and services. With annual sales of $12 billion and more than 44,000 associates, Ecolab delivers comprehensive solutions,...

Continue reading

Veritex Holdings, Inc. Announces Acquisition of North Avenue Capital, LLC

DALLAS, Sept. 21, 2021 (GLOBE NEWSWIRE) — Veritex Holdings, Inc. (Nasdaq: VBTX) (“Veritex” or the “Company”), the parent holding company of Veritex Community Bank, today announced the entry into a definitive agreement pursuant to which a newly formed subsidiary of Veritex Community Bank will acquire North Avenue Capital, LLC (“NAC” or “North Avenue Capital”) to be a subsidiary of Veritex Community Bank. The transaction will make Veritex Community Bank a leading player in the USDA Business and Industry (“B&I”) lending program. It furthers Veritex’s strategy of diversifying revenue streams and providing meaningful gain on sale and loan servicing fees. Veritex will be able to leverage NAC’s loan sourcing technology to further enhance Veritex’s products and services. Additionally, Veritex will provide additional resources and...

Continue reading

Dave & Buster’s Announces CEO Transition

DALLAS, Sept. 21, 2021 (GLOBE NEWSWIRE) — Dave & Buster’s Entertainment, Inc., (NASDAQ:PLAY), (“Dave & Buster’s” or “the Company”), an owner and operator of entertainment and dining venues, today announced that, following its recently announced record quarterly revenue and profit performance, Brian A. Jenkins will be retiring from his service as Chief Executive Officer of the Company and a member of its Board of Directors. By mutual agreement with the Company’s Board, Mr. Jenkins will continue to serve as CEO and a Board director through September 30, 2021. To ensure a seamless transition of responsibilities, he will become a Senior Advisor to the CEO until November 30, 2021. Concurrent with this announcement, effective October 1, 2021, the Board has appointed Kevin M. Sheehan, Chair...

Continue reading

Mercury Acquisitions Corp. Announces Results of Special Meeting

TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Mercury Acquisitions Corp. (the “Company” or “Mercury”) (TSXV: MERC.P) is pleased to announce shareholders of the Company approved all of the matters brought before them by the requisite majorities at the special meting of shareholders held on September 20, 2021 (the “Meeting”) as set out in the management information circular dated August 16, 2021. At the Meeting, it was resolved that upon the completion of the proposed qualifying transaction with Franchise Cannabis Corp. (the “Effective Time”): (i) the number of directors of the Company shall be fixed to five (5) members; (ii) Clifford Starke, Larry W. Smith, Peter Simeon, Jakub Malczewski, and Farhan Lalani shall be the directors of the Company; (iii) MNP LLP shall be the auditor of the Company; (iv) the Company’s stock option plan...

Continue reading

Kimball Electronics to Participate at the Sidoti Fall 2021 Virtual Investor Conference

Company Reaffirms Guidance With Supply Chain Disruptions Shifting More Shippable Backlog to Second Half of Fiscal 2022 JASPER, Ind., Sept. 21, 2021 (GLOBE NEWSWIRE) — Kimball Electronics, Inc. (Nasdaq: KE) today announced the company will be attending the Sidoti Fall 2021 Virtual Investor Conference. Donald D. Charron, Chairman and Chief Executive Officer, and Jana Croom, Vice President, Chief Financial Officer, will participate in a fireside chat on Thursday, September 23, 2021 at 10:00 AM ET. A webcast of the fireside chat will be available on the company website, on the Events & Presentations tab in the Investor Relations section, at https://investors.kimballelectronics.com/events-presentations. If you are unable to attend the live webcast, an archive will be available in this same location on the company website. In advance...

Continue reading

Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footprint in Seattle

New Partnership with Youth Organization STEM Paths Innovation Network (SPIN) Seeds Next Generation of Local Biotech Talent SEATTLE, Sept. 21, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced today the opening of its new corporate headquarters and laboratory facility located in the heart of South Lake Union – Seattle’s life sciences hub. “Washington is proud to be home to companies like Adaptive that are changing the future of medicine,” said keynote speaker Gov. Jay Inslee. “Our thriving life sciences community is world-class and will benefit our state and our world for generations. I am glad their new corporate headquarters and lab...

Continue reading

Isoray Announces Fourth Quarter and Full-Year Fiscal Year End 2021 Financial Results

Record Full Year RevenueFiscal Fourth Quarter Revenue Increased 19% Year-Over-Year RICHLAND, Wash., Sept. 21, 2021 (GLOBE NEWSWIRE) — Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced financial results for the fiscal fourth quarter and full-year ended June 30, 2021. Revenue for the fourth quarter of fiscal 2021 grew 19% to $2.71 million versus $2.28 million in the prior year comparable period. The Company’s core prostate brachytherapy revenue grew 5% when compared to the fiscal fourth quarter of 2020. Prostate brachytherapy represented 74% of total revenue for the fourth quarter of fiscal 2021 compared to 84% in the prior year comparable period. Record non-prostate brachytherapy revenue increased 92% versus...

Continue reading

InnovAge Announces Financial Results for the Fiscal Year and Fourth Quarter Ended June 30, 2021

DENVER, Sept. 21, 2021 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced financial results for its fiscal fourth quarter and full year ended June 30, 2021. “The InnovAge team is excited to deliver strong fourth quarter financial results to end the year with approximately 6,850 participants, an increase of 7.4% year-over-year,” said Maureen Hewitt, President and Chief Executive Officer, of InnovAge. “We produced $637.8 million of total revenues, an increase of approximately 12.5% compared to fiscal year 2020. During the pandemic, we opened two new centers and we remain on track to open de novo centers in two new states in fiscal year 2023. We also expanded our leadership team with the additions of Nicole...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.